Koss-Olinger Consulting’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $388K | Buy |
498
+28
| +6% | +$21.8K | 0.03% | 238 |
|
|
2025
Q1 | $388K | Buy |
+470
| New | +$388K | 0.03% | 231 |
|
|
2024
Q4 | – | Sell |
-497
| Closed | -$440K | – | 248 |
|
|
2024
Q3 | $440K | Sell |
497
-8
| -2% | -$7.08K | 0.04% | 177 |
|
|
2024
Q2 | $457K | Sell |
505
-6,120
| -92% | -$5.54M | 0.04% | 155 |
|
|
2024
Q1 | $5.15M | Buy |
+6,625
| New | +$5.15M | 2.79% | 21 |
|
|
2022
Q4 | – | Sell |
-822
| Closed | -$266K | – | 254 |
|
|
2022
Q3 | $266K | Hold |
822
| – | – | 0.05% | 174 |
|
|
2022
Q2 | $267K | Sell |
822
-287
| -26% | -$93.2K | 0.05% | 140 |
|
|
2022
Q1 | $318K | Sell |
1,109
-787
| -42% | -$226K | 0.05% | 146 |
|
|
2021
Q4 | $524K | Sell |
1,896
-108
| -5% | -$29.8K | 0.08% | 101 |
|
|
2021
Q3 | $463K | Sell |
2,004
-1,259
| -39% | -$291K | 0.08% | 120 |
|
|
2021
Q2 | $749K | Buy |
3,263
+347
| +12% | +$79.7K | 0.11% | 105 |
|
|
2021
Q1 | $545K | Buy |
+2,916
| New | +$545K | 0.09% | 118 |
|